Cargando…
Clinical impacts of sarcopenic obesity on chronic obstructive pulmonary disease: a cross-sectional study
BACKGROUND: Sarcopenia and obesity are two abnormal body composition phenotypes, and sarcopenic obesity (SO) is characterized by both low skeletal muscle mass (sarcopenia) and high adiposity (obesity). SO negatively influences the clinical status of patients with chronic obstructive pulmonary diseas...
Autores principales: | Wang, Zilin, Zhou, Xiaoming, Deng, Mingming, Yin, Yan, Li, Yanxia, Zhang, Qin, Bian, Yiding, Miao, Jinrui, Li, Jiaye, Hou, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585792/ https://www.ncbi.nlm.nih.gov/pubmed/37853348 http://dx.doi.org/10.1186/s12890-023-02702-2 |
Ejemplares similares
-
Prevalence and risk factors of sarcopenia in idiopathic pulmonary fibrosis: a systematic review and meta-analysis
por: Li, Jiaye, et al.
Publicado: (2023) -
Growth Differentiation Factor-15 as a Biomarker for Sarcopenia in Patients With Chronic Obstructive Pulmonary Disease
por: Deng, Mingming, et al.
Publicado: (2022) -
Glycyl‐l‐histidyl‐l‐lysine‐Cu(2+) rescues cigarette smoking‐induced skeletal muscle dysfunction via a sirtuin 1‐dependent pathway
por: Deng, Mingming, et al.
Publicado: (2023) -
Resistin as a Systemic Inflammation-Related Biomarker for Sarcopenia in Patients With Chronic Obstructive Pulmonary Disease
por: Gao, Jinghan, et al.
Publicado: (2022) -
Ultrasound Assessment of the Rectus Femoris in Patients with Chronic Obstructive Pulmonary Disease Predicts Sarcopenia
por: Deng, Mingming, et al.
Publicado: (2022)